Attached files

file filename
8-K - 8-K - CASCADE MICROTECH INCd716040d8k.htm

Exhibit 99.1

Cascade Microtech Reports First Quarter 2014 Results

Revenue of $33.8 million

Gross Margin of 48.1%

Income from Operations of $2.6 million

GAAP EPS of $0.10

BEAVERTON, Ore.—(MARKETWIRE) — April 29, 2014 —Cascade Microtech, Inc. (NASDAQ:CSCD) today reported financial results for the first quarter March 31, 2014.

Financial summary

Results for the quarter ended March 31, 2014 were as follows:

 

    Total revenue of $33.8 million, compared to $34.0 million for Q4 2013 and $27.5 million for Q1 2013.

 

  Systems revenue of $21.6 million, a decrease of $2.6 million, or 10.8%, from Q4 2013, and an increase of $3.9 million, or 21.8%, over Q1 2013.

 

  Probes revenue of $12.2 million, an increase of $2.4 million, or 24.3%, over Q4 2013, and an increase of $2.5 million, or 25.4%, over Q1 2013.

 

  Q1 2014 sets a new revenue record for our Probes segment.

 

    Gross margin of 48.1%, up from 45.5% in Q4 2013, and 42.0% in Q1 2013.

 

  Systems gross margin of 42.7%, up from 42.3% in Q4 2013, and 37.9% in Q1 2013.

 

  Probes gross margin of 57.8%, up from 53.3% in Q4 2013, and 49.4% in Q1 2013.

 

  Q1 2014 represents our best gross margin performance in 9 years.

 

    Income from operations of $2.6 million, an increase of $0.4 million, or 18.1%, over Q4 2013, and an increase of $1.6 million, or 150.0%, over Q1 2013.

 

    Net income of $1.6 million, or $0.10 per diluted share, compared to $8.8 million, or $0.53 per diluted share, for Q4 2013, and $0.7 million, or $0.05 per diluted share, for Q1 2013.

 

  Q1 2014 includes tax expense of $0.9 million, or $0.06 per diluted share, compared to a tax benefit of $6.6 million, or $0.40 per diluted share, for Q4 2013, and tax expense of $0.1 million, or $0.01 per diluted share, for Q1 2013.

 

    Non-GAAP net income of $0.13 per diluted share, compared to $0.21 per diluted share for Q4 2013 and $0.07 per diluted share for Q1 2013.

 

    Depreciation, amortization and stock-based compensation expenses totaled $2.1 million, compared to $2.1 million for Q4 2013 and $1.5 million for Q1 2013.

 

    Adjusted EBITDAS of $4.7 million, compared to $5.2 million for Q4 2013 and $2.6 million for Q1 2013.

 

    Total cash, restricted cash and investments of $28.5 million, an increase of $6.0 million over December 31, 2013.

 

  Q1 2014 includes stock repurchases of $0.8 million.

 

    Book-to-bill ratio of 0.92 to 1.

“We are pleased by the strong overall results of the first quarter. Both revenue and profitability were near the high end of our expectations due to record revenue and gross margins from our Probes segment. Favorable product mix drove the best overall gross margins for the company in over nine years, and cash grew $6 million quarter on quarter. Our new acquisitions performed well, and we continue to see improved market acceptance and sales of our new products. With a strong Q1 behind us, we are optimistic about the rest of 2014,” said Michael Burger, President and CEO.

Financial outlook

For the second quarter of 2014 we are projecting revenue in the range of $32.0 million to $35.0 million with diluted GAAP earnings per share in the range of $0.05 to $0.10, and non-GAAP earnings per share in the range of $0.08 to $0.13. Our guidance assumes a tax rate of 37%, consistent foreign currency rates and no significant one-time charges.

 

1


We will host a conference call beginning at 2:00 p.m. PDT (5:00 p.m. EDT) on Tuesday, April 29, 2014, to discuss our results for the quarter ended March 31, 2014.

A simultaneous audio cast of the conference call may be accessed online from the investor relations page of www.cascademicrotech.com. If you are interested in participating in the call, the live dial-in number is 866-515-2910, or international 617-399-5124, participant Passcode: 24546255. A replay will be available after 9:00 p.m. EDT at the same internet address. (For a telephone replay available after 9:00 p.m. EDT, dial: 888-286-8010, international: 617-801-6888, Passcode: 22751227).

Forward-Looking Statements

The statements in this release regarding performance of our new acquisitions, improved market acceptance and sales of our new products, our optimism about the rest of 2014, and statements under “Financial Outlook” regarding projected revenue, GAAP earnings per share and non-GAAP earnings per share, and other statements identified by terminology such as “will,” “should,” “expects,” “estimates,” “predicts,” and “continue” or other derivations of these or other comparable terms are “forward-looking” statements within the meaning of the Securities Litigation Reform act of 1995. Such statements are based on current expectations, estimates and projections about the Company’s business based in part on assumptions made by management. These statements are not guarantees of future performance and involve risks and uncertainties that are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or forecasted in such forward-looking statements due to numerous factors, including: changes in demand for the Company’s products; changes in product mix; potential delays and other factors affecting the timing of new product introductions; the timing of shipments and customer orders; constraints on supplies of components; excess or shortage of production capacity; potential failure of expected market opportunities to materialize; changes in foreign exchange rates; our ability or delay in integrating acquired businesses; and other risks discussed from time to time in the Company’s Securities and Exchange Commission filings and reports, including the Company’s Annual Report on Form 10-K for the year ended December 31, 2013. In addition, such statements could be affected by general industry and market conditions and growth rates and general domestic and international economic conditions. Such forward-looking statements speak only as of the date on which they are made and the Company does not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of this release.

Non-GAAP Financial Measures

In addition to disclosing financial results calculated in accordance with U.S. generally accepted accounting principles (GAAP), the Company’s earnings release contains Non-GAAP financial measures which are defined below and reconciled to GAAP financial measures in a table later in this release:

 

    Non-GAAP net income is defined as GAAP net income before certain items (adjustments) such as restructuring, facility move and project costs, acquisition-related expenses, the amortization of intangibles and discrete tax items that we believe are either not representative of our ongoing operating performance or effect the comparability of results over time. Non-GAAP net income should not be construed as a substitute for net income as defined by GAAP. However, we regard non-GAAP net income as a complement to GAAP net income in assessing our financial performance over time and in the future.

 

    Adjusted EBITDAS is defined as income from continuing operations before depreciation and amortization and stock-based compensation and certain other items (adjustments) such as restructuring, facility move and project costs, and acquisition-related expenses that we believe are not representative of our ongoing operating performance. Adjusted EBITDAS should not be construed as a substitute for net income from continuing operations or net cash provided by (used in) operating activities (all as determined in accordance with GAAP) for the purpose of analyzing our operating performance, financial position and cash flows, as adjusted EBITDAS is not defined by GAAP. However, we regard adjusted EBITDAS as a complement to net income from continuing operations and other GAAP financial performance measures, by including an indirect measure of operating cash flow.

About Cascade Microtech, Inc.

Cascade Microtech, Inc. (NASDAQ: CSCD) is a worldwide leader in precision contact, electrical measurement and test of integrated circuits (ICs), optical devices and other small structures. For technology businesses and

 

2


scientific institutions that need to evaluate small structures, Cascade Microtech delivers access to electrical data from wafers, ICs, IC packages, circuit boards and modules, MEMS, 3D TSV, LED devices and more. Cascade Microtech’s leading-edge stations, probes, probe cards, advanced thermal subsystems and integrated systems deliver precision accuracy and superior performance both in the lab and during production manufacturing of high-speed and high-density semiconductor chips. For more information, visit www.cascademicrotech.com.

FOR MORE INFORMATION, CONTACT:

Jeff A. Killian

Cascade Microtech, Inc.

(503) 601-1280

###

 

3


CASCADE MICROTECH, INC.

AND SUBSIDIARIES

Condensed Consolidated Statements of Operations

(in thousands, except per share data)

(unaudited)

 

     Three Months Ended  
     March 31,
2014
    March 31,
2013
    December 31,
2013
 

Revenue

   $ 33,810      $ 27,471      $ 34,035   

Cost of sales

     17,537        15,928        18,547   
  

 

 

   

 

 

   

 

 

 

Gross profit

     16,273        11,543        15,488   
  

 

 

   

 

 

   

 

 

 

Operating expenses:

      

Research and development

     3,241        2,456        3,061   

Selling, general and administrative

     10,430        8,046        10,223   
  

 

 

   

 

 

   

 

 

 
     13,671        10,502        13,284   
  

 

 

   

 

 

   

 

 

 

Income from operations

     2,602        1,041        2,204   
  

 

 

   

 

 

   

 

 

 

Other income (expense):

      

Interest income, net

     2        20        4   

Other, net

     (69     (244     (27
  

 

 

   

 

 

   

 

 

 
     (67     (224     (23
  

 

 

   

 

 

   

 

 

 

Income before income taxes

     2,535        817        2,181   

Income tax expense (benefit)

     943        70        (6,621
  

 

 

   

 

 

   

 

 

 

Net income

   $ 1,592      $ 747      $ 8,802   
  

 

 

   

 

 

   

 

 

 

Net income per share:

      

Basic

   $ 0.10      $ 0.05      $ 0.54   

Diluted

   $ 0.10      $ 0.05      $ 0.53   

Shares used in computing net income per share:

      

Basic

     16,242        14,227        16,173   

Diluted

     16,679        14,599        16,634   

 

4


CASCADE MICROTECH, INC.

AND SUBSIDIARIES

Condensed Consolidated Balance Sheets

(in thousands)

(unaudited)

 

     March 31,
2014
    December 31,
2013
 
Assets     

Current assets:

    

Cash and cash equivalents

   $ 24,945      $ 17,172   

Marketable securities

     2,737        4,278   

Restricted cash

     831        1,082   

Accounts receivable, net

     21,642        26,520   

Inventories

     25,598        24,884   

Deferred income taxes

     2,270        2,268   

Prepaid expenses and other

     2,616        2,147   
  

 

 

   

 

 

 

Total current assets

     80,639        78,351   

Fixed assets, net

     5,805        6,403   

Purchased intangible assets, net

     16,206        16,937   

Goodwill

     14,473        14,471   

Deferred income taxes

     1,236        1,235   

Other assets, net

     1,092        1,114   
  

 

 

   

 

 

 
   $ 119,451      $ 118,511   
  

 

 

   

 

 

 
Liabilities and Shareholders’ Equity     

Current liabilities:

    

Accounts payable

   $ 7,193      $ 7,229   

Deferred revenue

     2,092        2,555   

Accrued liabilities

     9,158        8,859   
  

 

 

   

 

 

 

Total current liabilities

     18,443        18,643   

Deferred revenue

     566        548   

Other long-term liabilities

     1,897        2,119   
  

 

 

   

 

 

 

Total liabilities

     20,906        21,310   
  

 

 

   

 

 

 

Shareholders’ equity:

    

Common stock

     107,808        108,070   

Accumulated other comprehensive income

     132        118   

Accumulated deficit

     (9,395     (10,987
  

 

 

   

 

 

 

Total shareholders’ equity

     98,545        97,201   
  

 

 

   

 

 

 
   $ 119,451      $ 118,511   
  

 

 

   

 

 

 

 

5


CASCADE MICROTECH, INC.

AND SUBSIDIARIES

Reconciliation of GAAP to Non-GAAP Financial Measures

(in thousands, except per share amounts)

(unaudited)

 

     Three Months Ended  
     March 31,
2014
    March 31,
2013
    December 31,
2013
 

Non-GAAP Net Income

      

GAAP net income

   $ 1,592      $ 747      $ 8,802   

Adjustments to net income:

      

Restructuring

     —          —          115   

Acquisition and acquisition related

     —          —          779   

Amortization of intangibles

     785        237        787   

Income tax effect of non-GAAP adjustments

     (291     (21     (168

Discrete tax items

     —          —          (6,840
  

 

 

   

 

 

   

 

 

 

Non-GAAP net income

   $ 2,086      $ 963      $ 3,475   
  

 

 

   

 

 

   

 

 

 

GAAP net income per diluted share

   $ 0.10      $ 0.05      $ 0.53   
  

 

 

   

 

 

   

 

 

 

Non-GAAP net income per diluted share

   $ 0.13      $ 0.07      $ 0.21   
  

 

 

   

 

 

   

 

 

 

Shares used in diluted share calculations

     16,679        14,599        16,634   
     Three Months Ended June 30, 2014  
     Low Range Guidance           High Range Guidance  

Forward-looking non-GAAP net income

      

GAAP net income

   $ 800        $ 1,600   

Adjustments:

      

Amortization of intangibles

     785          785   

Income tax effect of non-GAAP adjustments

     (291       (291
  

 

 

     

 

 

 

Non-GAAP Net Income

   $ 1,294        $ 2,094   
  

 

 

     

 

 

 

GAAP net income per diluted share

   $ 0.05        $ 0.10   
  

 

 

     

 

 

 

Non-GAAP net income per diluted share

   $ 0.08        $ 0.13   
  

 

 

     

 

 

 

Shares used in diluted share calculations

     16,750          16,750   
     Three Months Ended  
     March 31,
2014
    March 31,
2013
    December 31,
2013
 

EBITDAS and Adjusted EBITDAS

      

GAAP Income from operations

   $ 2,602      $ 1,041      $ 2,204   

Adjustments:

      

Depreciation

     829        963        874   

Amortization of intangibles

     785        237        787   

Stock-based compensation

     449        334        399   
  

 

 

   

 

 

   

 

 

 

EBITDAS

   $ 4,665      $ 2,575      $ 4,264   
  

 

 

   

 

 

   

 

 

 

Adjustments:

      

Restructuring

     —          —          115   

Acquisition and acquisition related

     —          —          779   
  

 

 

   

 

 

   

 

 

 

Adjusted EBITDAS

   $ 4,665      $ 2,575      $ 5,158   
  

 

 

   

 

 

   

 

 

 

 

6